Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Get well soon Matt

<< Previous

Bullboard Posts

Next >>

Comment by laroplexon Jun 24, 2024 8:38am

147 Views

Post# 36102923

RE:Get well soon Matt

Yes! Get well soon Matt....so saying this, another curve ball for us shareholders.....It is what it is....But, i got a giut feeking we will not see Matt Coffey as in the same position as our CEO in the future, blessing in disguise, i say yes...He'll probably have a lesser role in the company,....Just hope it's nothing too serious though, but as the saying goes, the show must go on.....GLTA

<< Previous

Bullboard Posts

Next >>

5 steps to mastering risk management in the stock market